Skip to main content
. 2020 Jul 17;40(7):BSR20194468. doi: 10.1042/BSR20194468

Table 4. Pool effects of Clinicopathologic characteristics in cancer patients with abnormal SNHG15 expression.

Clinicopathological characteristics No. of studies No. of patients Odds ratio (95% CI) Heterogeneity
Fixed Random I2(%) P-value
Age (old vs. young) 13 1271 0.98 (0.78–1.22) 0.98 (0.78–1.23) 0.0 0.680
gender (female vs. male) 11 1031 1.07 (0.83–1.37) 1.05 (0.78–1.41) 23 0.220
TNM (III+IV vs. I+II) 13 1271 1.98 (1.57–2.51) 2.52 (1.33–4.76) 83.9 0.000
  Digestive system 5 568 2.97 (2.09–4.23) 2.96 (2.08–4.23) 0 0.61
  Respiratory system 3 139 3.04 (1.52–6.09) 2.95 (1.13–7.73) 45 0.16
  Female reproductive system 1 182 2.14 (0.99–4.61) 2.14 (0.99–4.61) - -
  Other system malignancy 4 382 0.96 (0.64–1.45) 1.91 (0.21–17.20) 94 0.000
LNM (present vs. absent) 11 937 2.09 (1.65–2.64) 2.41 (0.99–5.87) 87 0.000
  Digestive system 4 416 3.00 (2.00–4.51) 2.98 (1.98–4.49) 0 0.450
  Respiratory system 3 139 3.40 (1.67–6.91) 3.39 (1.66–6.93) 0 0.67
  Other system malignancy 4 382 0.71 (0.46-1.09) 1.39 (0.09–20.34) 95 0.000
Tumor size (big vs. small) 8 761 1.48 (1.11–1.97) 2.06 (1.03–4.13) 79.0 0.000
  Digestive system 3 371 1.24 (0.82–1.88) 1.47 (0.56–3.88) 77.0 0.010
  Respiratory system 2 104 4.63 (2.02–10.66) 4.63 (2.01–10.66) 0 0.81
  Other system malignancy 3 286 1.26 (0.79–2.02) 1.88 (0.41–8.59) 87.0 0.000
Histological grade 7 701 2.62 (1.90–3.59) 2.59 (1.84–3.64) 9.0 0.360
  Digestive system 5 570 2.63 (1.84–3.76) 2.64 (1.84–3.77) 0.0 0.550
  Non-digestive system 2 131 2.56 (1.27–5.15) 2.05 (0.47–-9.04) 72.0 0.060
DM (present vs. absent) 5 521 1.66 (1.02–2.72) 1.64 (0.40–6.74) 73.0 0.005
  Digestive system 2 197 5.05 (2.15–11.85) 5.10 (2.17–11.96) 0.0 0.430
  Non-digestive system 3 324 0.83 (0.43–1.61) 0.66 (0.03–12.65) 80.0 0.007
Invasion depth (T3+T4/T1+T2) 3 349 4.13 (2.55–6.67) 3.60 (0.95–13.66) 84 0.002
smoking (smoker vs. non-smoker) 2 84 1.03 (0.24–2.54) 1.15 (0.26–5.11) 59.0 0.120

Abbreviations: DM, distant metastasis; LNM, lymph node metastasis. Random, random-effect model; TNM, TNM stage; Fixed, fixed-effect model.